Skip to Content

AptarGroup Inc

ATR: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$567.00JqhqhhNcfmwsww

Aptar Earnings: Profitability Continues to Improve; Narrow Moat Affirmed and FVE Raised to $147

Aptar's fourth-quarter earnings outperformed our expectations due to better profit margins. We have also reviewed our thoughts on the company, affirming our narrow moat rating thanks to the strong intangibles and switching costs we see in its Pharma segment. We have revised our fair value to $147 per share from $132 previously, too, to reflect our assumption of continued improvement in profitability.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ATR so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center